Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Metastatic Penile Carcinoma
NCT02014831Phase 2Withdrawn
- Sponsor
- Centre Léon Bérard
- Start
- Feb 2016
- Primary completion
- Feb 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in penile carcinoma, sponsored by Centre Léon Bérard. Planned start Feb 2016; status: withdrawn.
02
Drugs
KL-140
03
Conditions
penile carcinoma
Beyond the preview
Go deeper on NCT02014831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014831.